Novo Nordisk's pricing techniques during the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who has accused the company of price gouging, mentioning the stark distinction among U.S. price ranges and those in Europe and copyright.The manufacturer claims that correct utilization of copyright, along with eating plan and exercise,